Research Papers:

Sphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancer

Jessica A. Beach, Paul-Joseph P. Aspuria, Dong-Joo Cheon, Kate Lawrenson, Hasmik Agadjanian, Christine S. Walsh, Beth Y. Karlan and Sandra Orsulic _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:4167-4182. https://doi.org/10.18632/oncotarget.6703

Metrics: PDF 2605 views  |   HTML 3922 views  |   ?  


Jessica A. Beach1,2,*, Paul-Joseph P. Aspuria1,*, Dong-Joo Cheon1, Kate Lawrenson1, Hasmik Agadjanian1, Christine S. Walsh1,3, Beth Y. Karlan1,3, and Sandra Orsulic1,3

1Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA

2Graduate Program in Biomedical Science and Translational Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA

3Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA

*These authors have contributed equally to this work

Correspondence to:

Sandra Orsulic, e-mail: [email protected]

Keywords: sphingosine kinase 1 (SPHK1), cancer-associated fibroblast (CAF), transforming growth factor-beta 1 (TGF-β1), sphingosine-1-phosphate (S1P), microenvironment

Received: August 18, 2015    Accepted: December 05, 2015    Published: December 21, 2015


Sphingosine kinase 1 (SPHK1), the enzyme that produces sphingosine 1 phosphate (S1P), is known to be highly expressed in many cancers. However, the role of SPHK1 in cells of the tumor stroma remains unclear. Here, we show that SPHK1 is highly expressed in the tumor stroma of high-grade serous ovarian cancer (HGSC), and is required for the differentiation and tumor promoting function of cancer-associated fibroblasts (CAFs). Knockout or pharmacological inhibition of SPHK1 in ovarian fibroblasts attenuated TGF-β-induced expression of CAF markers, and reduced their ability to promote ovarian cancer cell migration and invasion in a coculture system. Mechanistically, we determined that SPHK1 mediates TGF-β signaling via the transactivation of S1P receptors (S1PR2 and S1PR3), leading to p38 MAPK phosphorylation. The importance of stromal SPHK1 in tumorigenesis was confirmed in vivo, by demonstrating a significant reduction of tumor growth and metastasis in SPHK1 knockout mice. Collectively, these findings demonstrate the potential of SPHK1 inhibition as a novel stroma-targeted therapy in HGSC.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 6703